RXI PHARMACEUTICALS CORP NEW's ticker is RXIIW and the CUSIP is 74979C113. A total of 4 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 2,221,722 | $1,235,000 | 0.83% |
| SABBY MANAGEMENT, LLC | 2,100,797 | $273,000 | 0.02% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 30,000 | $4,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,216,855 | $288,000 | 0.00% |